
|Articles|March 17, 2004
Inconclusive findings lead Pfizer to stop testing sildenafil in women
Pfizer Inc. has ended its research into sildenafil citrate (Viagra) as a treatment for female sexual arousal disorder (FSAD) after several large studies showed inconclusive efficacy.
Advertisement
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The ArteraAI Prostate Test: What It Is and How It Works
2
HHS requests testosterone therapy label updates, citing new safety data
3
FDA approves tebipenem pivoxil for complicated urinary tract infections
4
The UroOnc Minute: Keeping Patients Engaged in Active Surveillance, With Lourdes Guerrios-Rivera, MD, MSc
5










